Age | Median: 67 years |
Range: 20–95 years | |
Gender | 51 male |
38 female | |
Location | 60% lower extremity |
18% upper extremity | |
12% trunk | |
10% pelvis | |
Stage (Enneking) | 51% stage IIB |
31% stage IIA | |
10% stage IB | |
8% stage IA | |
Local invasion | 96% deep-seated (subfacial) |
4% superficial (subcutaneous) |